Talquetamab (anti–G protein–coupled receptor family C group 5 member D) and teclistamab (anti–B-cell maturation antigen) are bispecific antibodies that activate T cells by targeting CD3 and that ha…
This study aims to characterize the individual-level agreement of polygenic risk scores for coronary heart disease that perform similarly at the population level.
Panelists discuss current statistics indicating that COPD is one of the top three leading causes of death worldwide, with high morbidity and mortality rates, particularly…
The 43rd annual J.P. Morgan Healthcare Conference will feature presentations from more than 500 private and public companies.
THURSDAY, Jan. 9, 2025 (HealthDay News) — Exercising now can increase your chances of successfully fighting cancer in the future.Even low levels of exercise pr
NHS employers need a proactive and consistent approach to protecting the mental health of resident doctors, write Alexander Mafi and Jaya Sharma “No one else…
Daratumumab is an anti-CD38 monoclonal antibody approved for treatment of active multiple myeloma. Smoldering myeloma, defined as monoclonal protein
“This report highlights that the physician community is working on multiple fronts to remove barriers to evidence-based care for patients with substance use disorders and…
Producers of hi-tech connected eyewear are multiplying their innovations with increasingly discreet models in an attempt to make a difference in a highly competitive —…
Do you have trouble falling asleep? If meditation apps and sleep trackers aren’t cutting it, now there’s technology designed to help users not only nod…
Trio behind MyoKardia raise $300 million for new biotech firm focused on heart disease.
